|
Index of reports
> Disability (35)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rebetol (Ribavirin) disability. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 35 Next >>
Possible Rebetol side effects in
Reported by a pharmacist from United States on 2012-08-23
Patient:
Reactions: Dyspnoea, Chest Discomfort, Anaemia, Blood Pressure Decreased, Asthenia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Rebetol
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2012-05-16
Pegasys
Dosage: unk
Start date: 2012-05-16
Victrelis
Dosage: 200 mg, tid
Administration route: Oral
Start date: 2012-06-27
End date: 2012-07-03
Other drugs received by patient: Imdur; Aspirin; Calcium 500; Vitamin B Complex CAP; Metoprolol Tartrate; Hydralazine HCL; Fish OIL; Tricor; Cardura; Procardia XL; Lasix
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Cheilitis, Rash
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Telavic
Dosage: 2250 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-29
End date: 2012-05-31
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-29
Telavic
Administration route: Oral
Start date: 2012-06-01
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-29
Other drugs received by patient: Urso 250
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: daily dosage unknown
Indication: Hepatitis C
Start date: 2010-01-01
Rebetol
Dosage: daily dosage unknown
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-01-01
Possible Rebetol side effects in 65 year old male
Reported by a individual with unspecified qualification from France on 2012-08-22
Patient: 65 year old male, weighing 84.0 kg (184.8 pounds)
Reactions: Visual Acuity Reduced, Libido Decreased, Skin Discomfort, DRY Mouth, Neutropenia, Retinal Vein Thrombosis, Thrombocytopenia, Proctalgia, Retinopathy Proliferative, Leukopenia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Start date: 2006-09-28
Peginterferon Alfa-2B
Dosage: 135 ?g, qw
Indication: Hepatitis C
Start date: 2006-03-21
End date: 2006-09-28
Rebetol
Dosage: 1200 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-03-21
End date: 2006-09-28
Other drugs received by patient: Amlodipine Besylate; Irbesartan; Indapamide; Potassium Chloride; Perindopril Erbumine
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Haemoglobin Decreased, Anaemia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Start date: 2012-06-05
End date: 2012-06-25
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-05
End date: 2012-07-10
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-05
End date: 2012-07-10
PEG-Intron
Dosage: 1.5mcg/kg
Indication: Hepatitis C
Start date: 2012-06-05
End date: 2012-07-10
PEG-Intron
Dosage: 50mcg/week
Start date: 2012-06-26
End date: 2012-07-09
Other drugs received by patient: Miglitol; Metformin HCL
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Viral Load Increased, Vomiting, Contusion, Paranoia, Hyperhidrosis, Polyneuropathy, Joint Stiffness, Hallucination, Visual, Diarrhoea, Treatment Failure, Infection
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Start date: 2008-01-01
End date: 2008-07-01
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2006-12-01
End date: 2007-08-01
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2006-12-01
End date: 2007-08-01
Rebetol
Dosage: unk
Start date: 2008-01-01
End date: 2008-07-01
Possible Rebetol side effects in
Reported by a physician from United States on 2012-08-09
Patient:
Reactions: Bowel Movement Irregularity, Tinnitus, Feeling Hot, Anaemia, Loss of Consciousness
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2011-08-20
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2011-07-22
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2011-07-22
Possible Rebetol side effects in
Reported by a consumer/non-health professional from United States on 2012-08-09
Patient:
Reactions: Bowel Movement Irregularity, Tinnitus, Feeling Hot, Anaemia, Loss of Consciousness
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2011-07-22
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2011-07-22
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2011-08-20
Possible Rebetol side effects in
Reported by a consumer/non-health professional from United States on 2012-08-07
Patient:
Reactions: Procedural Pain, Back Pain, Hepatic Pain, Arthralgia, Panic Reaction, Influenza Like Illness
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-29
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-29
Possible Rebetol side effects in 65 year old male
Reported by a individual with unspecified qualification from France on 2012-08-06
Patient: 65 year old male, weighing 84.0 kg (184.8 pounds)
Reactions: Libido Decreased, Visual Acuity Reduced, Skin Discomfort, DRY Mouth, Retinal Vein Thrombosis, Neutropenia, Thrombocytopenia, Retinopathy Proliferative, Leukopenia, Proctalgia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Start date: 2006-09-28
Viraferonpeg
Dosage: 135 ?g, qw
Indication: Hepatitis C
Start date: 2006-03-21
End date: 2006-09-28
Rebetol
Dosage: 1200 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-03-21
End date: 2006-09-28
Other drugs received by patient: Perindopril Erbumine; Irbesartan; Indapamide; Potassium Chloride; Amlodipine Besylate
Possible Rebetol side effects in
Reported by a individual with unspecified qualification from France on 2012-07-26
Patient:
Reactions: Libido Decreased, Visual Acuity Reduced, Skin Discomfort, DRY Mouth, Neutropenia, Retinal Vein Thrombosis, Thrombocytopenia, Proctalgia, Leukopenia, Retinopathy Proliferative
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Viraferonpeg
Dosage: 135 ?g, qw
Indication: Hepatitis C
Start date: 2006-03-21
End date: 2006-09-28
Rebetol
Dosage: 1200 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-03-21
End date: 2006-09-28
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Start date: 2006-09-28
Other drugs received by patient: Perindopril Erbumine; Indapamide; Irbesartan; Amlodipine Besylate; Potassium Chloride
Possible Rebetol side effects in
Reported by a physician from United States on 2012-07-23
Patient:
Reactions: Encephalopathy, Ascites
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Victrelis
Dosage: 200 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-02
End date: 2012-06-08
Rebetol
Indication: Hepatitis C
PEG-Intron
Indication: Hepatitis C
Possible Rebetol side effects in
Reported by a consumer/non-health professional from United States on 2012-07-20
Patient:
Reactions: Disability
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Rebetol
Dosage: unk
Start date: 2011-12-01
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2011-12-01
Other drugs received by patient: Pegasys
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-19
Patient:
Reactions: Bowel Movement Irregularity, Tinnitus, Anaemia, Feeling Hot, Loss of Consciousness
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2011-08-20
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2011-07-22
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2011-07-22
Possible Rebetol side effects in
Reported by a physician from Bulgaria on 2012-07-19
Patient:
Reactions: Macular Oedema, Blindness, Papilloedema
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Rebetol
Administration route: Oral
Indication: Hepatitis C
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16
Patient:
Reactions: Dehydration, Anaemia, Asthenia, Muscle Spasms
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Rebetol
Dosage: 1000 mg, qd
Indication: Hepatitis C
End date: 2012-04-29
Victrelis
Dosage: 200 mg, tid
Indication: Hepatitis C
End date: 2012-04-29
Other drugs received by patient: Pegasys
Possible Rebetol side effects in 68 year old male
Reported by a physician from Japan on 2012-06-11
Patient: 68 year old male, weighing 61.0 kg (134.2 pounds)
Reactions: Blood Bilirubin Increased, Contusion, Pruritus, Ear Haemorrhage, Anaemia, Laceration, Rash, Fall, Subdural Haematoma, Skull Fractured Base, Hearing Impaired, Blood Creatinine Increased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 mcg/kg, qw, sc
Indication: Hepatitis C
Start date: 2012-02-02
Rebetol
Dosage: 800;600;400;200 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-06
End date: 2012-04-19
Rebetol
Dosage: 800;600;400;200 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-20
Rebetol
Dosage: 800;600;400;200 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-02-29
Rebetol
Dosage: 800;600;400;200 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-01
End date: 2012-04-05
Telavic (Antivirals Nos)
Dosage: 2250;1500 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-04-26
Telavic (Antivirals Nos)
Dosage: 2250;1500 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-04-12
Other drugs received by patient: Voltaren; Actos; Glyburide; Epadel-S; Actos
Possible Rebetol side effects in 59 year old female
Reported by a physician from Japan on 2012-05-30
Patient: 59 year old female, weighing 79.0 kg (173.8 pounds)
Reactions: Subarachnoid Haemorrhage, Platelet Count Decreased, Intracranial Aneurysm, Hypoaesthesia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 mcg;qw;sc, 100 mcg;qw;sc, 80 mcg;qw;sc
Indication: Hepatitis C
Start date: 2010-12-17
End date: 2011-01-14
PEG-Intron
Dosage: 120 mcg;qw;sc, 100 mcg;qw;sc, 80 mcg;qw;sc
Indication: Hepatitis C
Start date: 2011-01-21
End date: 2011-01-27
PEG-Intron
Dosage: 120 mcg;qw;sc, 100 mcg;qw;sc, 80 mcg;qw;sc
Indication: Hepatitis C
Start date: 2010-11-05
End date: 2010-12-10
Rebetol
Dosage: 400 mg;bid;po, 200 mg;bid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-11-05
End date: 2011-02-03
Rebetol
Dosage: 400 mg;bid;po, 200 mg;bid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-02-04
End date: 2012-01-28
Other drugs received by patient: Amlodipine / 00972402 /; Miglitol; Juzentaihoto
Possible Rebetol side effects in 59 year old male
Reported by a physician from France on 2012-05-25
Patient: 59 year old male, weighing 58.0 kg (127.6 pounds)
Reactions: Prostatitis, Autonomic Nervous System Imbalance, Hypotension, Malnutrition, Anaemia, Asthenia, Decreased Appetite
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Victrelis
Dosage: 800 mg, tid
Indication: Hepatitis C
Start date: 2011-09-27
Viraferonpeg
Dosage: 80 mcg. qw
Indication: Hepatitis C
Start date: 2011-08-25
Rebetol
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2011-08-25
Other drugs received by patient: Truvada; Isentress
Possible Rebetol side effects in 59 year old male
Reported by a physician from France on 2012-05-25
Patient: 59 year old male, weighing 58.0 kg (127.6 pounds)
Reactions: Prostatitis, Anaemia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Viraferonpeg
Dosage: 80 mcg, qw
Indication: Hepatitis C
Start date: 2011-08-25
Victrelis (Sch-503034)
Dosage: 800 mg, tid
Indication: Hepatitis C
Start date: 2011-09-27
Rebetol
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2011-08-25
Other drugs received by patient: Isentress; Truvada
Possible Rebetol side effects in 68 year old male
Reported by a physician from Japan on 2012-05-25
Patient: 68 year old male, weighing 61.0 kg (134.2 pounds)
Reactions: Blood Bilirubin Increased, Contusion, Ear Haemorrhage, Anaemia, Fall, Ear Canal Injury, Skull Fractured Base, Hearing Impaired
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 mcg/kg, qw, sc
Indication: Hepatitis C
Start date: 2012-02-02
Rebetol
Dosage: 800;600 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-01
Rebetol
Dosage: 800;600 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-02-29
Other drugs received by patient: Glyburide; Actos; Epadel-S; Voltaren
Possible Rebetol side effects in 18 year old male
Reported by a physician from Germany on 2012-05-07
Patient: 18 year old male
Reactions: Retinal Detachment, Retinitis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Boceprevir (Sch-503034)
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-02-03
End date: 2010-12-08
Rebetol
Dosage: 200 mg;bid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-01-06
End date: 2010-12-08
Peginterferon Alfa-2B
Dosage: 150 mcg;qw;sc 107 mcg;qw
Indication: Hepatitis C
Start date: 2010-01-08
End date: 2010-12-03
Other drugs received by patient: Amphotericin B; Xylocaine; Itraconazole
Possible Rebetol side effects in 68 year old male
Reported by a physician from Japan on 2012-04-16
Patient: 68 year old male, weighing 61.0 kg (134.2 pounds)
Reactions: Haemoglobin Decreased, Contusion, Ear Haemorrhage, Hearing Impaired, Skull Fractured Base, Fall
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Telavic (Antivirals Nos)
Dosage: 2250 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
Rebetol
Dosage: 800 mg;qd;po 600 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-01
Rebetol
Dosage: 800 mg;qd;po 600 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-02-29
PEG-Intron
Dosage: 1.5 mcg/kg;qw;sc
Indication: Hepatitis C
Other drugs received by patient: Actos; Glyburide; Voltaren; Epadel-S
Possible Rebetol side effects in 41 year old female
Reported by a physician from Italy on 2012-02-24
Patient: 41 year old female
Reactions: Dermatitis Allergic, Irritability, Speech Disorder, Fatigue, Wheezing, Facial Spasm
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Rebetol
Dosage: 800 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-05
End date: 2011-12-15
Peginterferon Alfa-2B
Dosage: 90 mcg;qw;sc
Indication: Hepatitis C
Start date: 2011-11-05
End date: 2011-12-15
Possible Rebetol side effects in 65 year old male
Reported by a physician from France on 2012-01-20
Patient: 65 year old male, weighing 80.0 kg (176.0 pounds)
Reactions: Portal Hypertension, Abdominal Pain, Weight Decreased, Lymphadenopathy, Metastases To Liver, Hepatic Lesion, Gastritis, Laboratory Test Abnormal, Metastases To Lung, Haemochromatosis, Hepatic Cirrhosis, Metastatic Neoplasm, Lung Neoplasm, General Physical Health Deterioration, Tumour Compression, Ascites, Dolichocolon, Retroperitoneal Neoplasm, Impaired Gastric Emptying
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Viraferonpeg
Dosage: 150 mcg;qw;sc
Indication: Hepatic Cirrhosis
Start date: 2011-02-26
End date: 2011-09-01
Viraferonpeg
Dosage: 150 mcg;qw;sc
Indication: Hepatitis C
Start date: 2011-02-26
End date: 2011-09-01
Victrelis
Dosage: 12 df;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-03-26
End date: 2011-09-01
Victrelis
Dosage: 12 df;qd;po
Administration route: Oral
Indication: Hepatic Cirrhosis
Start date: 2011-03-26
End date: 2011-09-01
Rebetol
Dosage: 1200 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-02-26
End date: 2011-09-01
Rebetol
Dosage: 1200 mg;qd;po
Administration route: Oral
Indication: Hepatic Cirrhosis
Start date: 2011-02-26
End date: 2011-09-01
Other drugs received by patient: Neorecormon
Possible Rebetol side effects in 41 year old female
Reported by a physician from Italy on 2012-01-20
Patient: 41 year old female
Reactions: Speech Disorder, Irritability, Dermatitis Allergic, Fatigue, Wheezing, Facial Spasm
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Rebetol
Dosage: 800 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-05
End date: 2011-12-15
PEG-Intron
Dosage: 90 mcg;qw;sc
Indication: Hepatitis C
Start date: 2011-11-05
End date: 2011-12-15
Possible Rebetol side effects in 61 year old male
Reported by a physician from Portugal on 2012-01-11
Patient: 61 year old male
Reactions: Chronic Myeloid Leukaemia
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Rebetol
Indication: Hepatitis C
Rebetol
Indication: Hepatic Cirrhosis
Victrelis
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Hepatitis C
End date: 2011-12-17
Victrelis
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Hepatic Cirrhosis
End date: 2011-12-17
PEG-Intron
Indication: Hepatic Cirrhosis
PEG-Intron
Indication: Hepatitis C
Other drugs received by patient: Prinzide; Pantoprazole; Lisinopril-Ratiopharm; Normacol
Possible Rebetol side effects in 63 year old male
Reported by a physician from Japan on 2011-12-30
Patient: 63 year old male, weighing 52.0 kg (114.4 pounds)
Reactions: Fibrin D Dimer Increased, Retinal Vein Occlusion, Retinal Artery Occlusion
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Rebetol
Dosage: 600 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2008-10-02
End date: 2009-04-01
PEG-Intron
Dosage: 80 mcg;qw;sc
Indication: Hepatitis C
Start date: 2008-10-02
End date: 2009-03-26
Possible Rebetol side effects in 64 year old male
Reported by a physician from France on 2011-12-28
Patient: 64 year old male, weighing 68.3 kg (150.3 pounds)
Reactions: Foot Fracture, Hepatic Neoplasm Malignant, Anaemia, Fall, Hepatic Cirrhosis
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Boceprevir (Sch-503034)
Dosage: 800 mg;tid;po, 600 mg; tid; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-14
Boceprevir (Sch-503034)
Dosage: 800 mg;tid;po, 600 mg; tid; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-04-26
End date: 2011-09-13
Rebetol
Dosage: 600 mg; qd; po, 400 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-03-29
End date: 2011-09-13
Rebetol
Dosage: 600 mg; qd; po, 400 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-14
Viraferonpeg
Dosage: 90 mcg; qw; sc, 80 mcg; qw; sc,
Indication: Hepatitis C
Start date: 2011-03-29
End date: 2011-09-12
Viraferonpeg
Dosage: 90 mcg; qw; sc, 80 mcg; qw; sc,
Indication: Hepatitis C
Start date: 2011-09-13
Other drugs received by patient: Neorecormon; Ferrous Sulfate TAB
Possible Rebetol side effects in 44 year old female
Reported by a consumer/non-health professional from United States on 2011-12-20
Patient: 44 year old female
Reactions: Impaired Work Ability, Gait Disturbance, Amnesia, Vaginal Haemorrhage
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Rebetol
Indication: Hepatitis C
Page 1 Next >>
|
